Read More Pharma Industry News Teva’s AJOVY shows promising results in migraine prevention Phase IV study New interim analysis from the pan-European PEARL Phase IV study reveals that Teva Pharmaceutical Industries’ AJOVY (fremanezumab) has… byPallavi MadhirajuJuly 1, 2023